metaxalone

Generic: metaxalone

Labeler: phoenix rx llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metaxalone
Generic Name metaxalone
Labeler phoenix rx llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

metaxalone 800 mg/1

Manufacturer
PHOENIX RX LLC

Identifiers & Regulatory

Product NDC 85509-1435
Product ID 85509-1435_413b2fa9-d4bd-3aed-e063-6394a90a0835
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204770
Listing Expiration 2026-12-31
Marketing Start 2016-11-22

Pharmacologic Class

Established (EPC)
muscle relaxant [epc]
Physiologic Effect
centrally-mediated muscle relaxation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 855091435
Hyphenated Format 85509-1435

Supplemental Identifiers

RxCUI
351254
UNII
1NMA9J598Y
NUI
N0000175730 N0000175737

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metaxalone (source: ndc)
Generic Name metaxalone (source: ndc)
Application Number ANDA204770 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (85509-1435-1)
  • 30 TABLET in 1 BOTTLE (85509-1435-3)
  • 60 TABLET in 1 BOTTLE (85509-1435-6)
  • 90 TABLET in 1 BOTTLE (85509-1435-9)
source: ndc

Packages (4)

Ingredients (1)

metaxalone (800 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "413b2fa9-d4bd-3aed-e063-6394a90a0835", "openfda": {"nui": ["N0000175730", "N0000175737"], "unii": ["1NMA9J598Y"], "rxcui": ["351254"], "spl_set_id": ["413b300d-4163-afef-e063-6394a90a618f"], "pharm_class_pe": ["Centrally-mediated Muscle Relaxation [PE]"], "pharm_class_epc": ["Muscle Relaxant [EPC]"], "manufacturer_name": ["PHOENIX RX LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (85509-1435-1)", "package_ndc": "85509-1435-1", "marketing_start_date": "20251016"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (85509-1435-3)", "package_ndc": "85509-1435-3", "marketing_start_date": "20251016"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (85509-1435-6)", "package_ndc": "85509-1435-6", "marketing_start_date": "20251016"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (85509-1435-9)", "package_ndc": "85509-1435-9", "marketing_start_date": "20251016"}], "brand_name": "Metaxalone", "product_id": "85509-1435_413b2fa9-d4bd-3aed-e063-6394a90a0835", "dosage_form": "TABLET", "pharm_class": ["Centrally-mediated Muscle Relaxation [PE]", "Muscle Relaxant [EPC]"], "product_ndc": "85509-1435", "generic_name": "Metaxalone", "labeler_name": "PHOENIX RX LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Metaxalone", "active_ingredients": [{"name": "METAXALONE", "strength": "800 mg/1"}], "application_number": "ANDA204770", "marketing_category": "ANDA", "marketing_start_date": "20161122", "listing_expiration_date": "20261231"}